0
0
April 16, 2025 – As the United States emerges from what the Centers for Disease Control and Prevention (CDC) has labeled a “high severity” seasonal flu season for 2024-2025, marked by the highest hospitalization rates in 15 years, attention is increasingly turning to a different influenza threat: avian influenza, or bird flu. While seasonal flu infections are currently trending downward, the ongoing spread of the H5N1 bird flu strain in animals, and its limited jump to humans, raises questions and concerns.
Since early 2024, the H5N1 virus has been detected widely in birds and, significantly, in cattle across the U.S. According to data current as of April 8, 2025, this specific outbreak has led to 70 documented human infections in the U.S., resulting in two deaths. While public health officials maintain that the immediate risk to the general public remains low, the potential for the virus to mutate and gain the ability to spread between people is a key concern for infectious disease experts.
Understanding the distinctions between seasonal flu and the H5N1 bird flu is crucial, explains an immunology doctoral candidate studying pathogen-immune system interactions. Both are influenza viruses, but they differ significantly.
What is Influenza?
Influenza viruses, part of the Orthomyxoviridae family, have plagued humanity for centuries, with potential references dating back to ancient Greece and the first recorded pandemic in 1518. The World Health Organization estimates 1 billion infections occur annually, leading to millions of severe cases and hundreds of thousands of deaths globally.
Influenza viruses are categorized into types A, B, C, and D. Types A and B are responsible for most significant human illnesses and seasonal epidemics. Influenza A viruses, like the H1N1 strain behind the 1918 Spanish Flu and the 2009 Swine Flu pandemics, possess the unique ability to cause global pandemics. Influenza B also causes seasonal illness but hasn’t caused a pandemic. Type C typically causes mild illness, and Type D is not known to infect humans.
Seasonal Flu vs. Bird Flu (H5N1)
Seasonal flu, which typically circulates from October to May, is caused by annually emerging strains of Influenza A (commonly H1N1 and H3N2 recently) and Influenza B. The CDC monitors these circulating strains, and the FDA uses this data to recommend the composition of the seasonal flu vaccine for the following year. Standard rapid flu tests usually identify whether an infection is Type A or B.
Crucially, the current seasonal flu vaccines are not designed to protect against the H5N1 avian influenza strain. H5N1 is an Influenza A virus primarily adapted to birds. While it would likely register as “Influenza A” on a standard rapid test, specific laboratory testing is required to confirm an H5N1 infection, typically only performed if exposure to infected animals is suspected. There is currently no commercially available human vaccine specifically for H5N1, though development efforts exist.
H5N1 Transmission and Potential Danger
Human cases of H5N1 were first reported in Hong Kong in 1997, mainly affecting individuals with close contact with infected poultry. The current North American H5N1 outbreak began in 2021. A major development occurred in March 2024 when H5N1 was found infecting dairy cows, followed by the first reported case of human infection linked to cattle in April 2024 (Texas), marking documented mammal-to-mammal transmission leading to a human case.
Globally, since 1997, there have been 988 human H5N1 cases reported, with a high fatality rate of around 50%. However, experts stress that there have been no confirmed reports of sustained H5N1 transmission directly between humans.
The primary concern lies in the nature of influenza viruses. They can mutate, and notably, undergo “reassortment” – a process where different strains infecting the same host cell swap genetic material. This can create novel viruses with altered characteristics, potentially allowing an animal strain like H5N1 to adapt to infect humans more easily and spread efficiently person-to-person. Because humans would lack immunity to such a novel strain, the potential for a pandemic exists.
Monitoring Efforts
Both the CDC and the U.S. Department of Agriculture (USDA) operate surveillance systems to monitor influenza strains circulating in human and animal populations, respectively. These systems are vital for detecting changes in the virus, assessing public health threats, and enabling rapid response if H5N1 shows signs of adapting for easier human transmission.
While the immediate danger from H5N1 to the public is low, the ongoing animal outbreaks and sporadic human infections underscore the importance of vigilance and robust surveillance.
Disclaimer: This news article is based on information provided by “The Conversation” summarizing research insights from an immunology doctoral candidate. It is intended for informational purposes only and does not constitute medical advice. Consult with healthcare professionals for any health concerns. Information regarding case numbers and dates is accurate according to the source material provided.
